Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Late dumping syndrome after fundoplication can be diagnosed with an oral glucose tolerance test and managed with diet changes.

Older age, higher BMI, and family history of diabetes increase the risk of gestational diabetes in pregnant women.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Higher SFRP-4 levels were found in people without a diabetic family history.

Obese and lean women with PCOS have different symptoms and need different treatments.

Hibiscus syriacus L. flower extracts may help lower blood sugar and improve cholesterol in diabetes.

Skin conditions can signal diabetes and insulin resistance.

Allium ascalonicum L. extract may help improve insulin resistance.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.